88352451
Mar 22, 2019
Oct 13, 2020
ULTRAGENYX PHARMACEUTICAL INC.
Active Trademark
pharmaceuticals for use in treating genetic disorders, autosomal disorders, lysosomal storage disorders, metabolic disorders, energy deficiency disorders, and enzyme disorders; pharmaceuticals for use in treating long-chain fatty acid oxidation disorders (LC-FAOD)
Pharmaceuticals